KERTYOL PSO
Treatment shampoo
KERTYOL PSO shampoo is specifically indicated for the management of scalp psoriasis.
The innovative formula allows an action at all levels of the physiopathology of psoriasis. This treatment can be used in combination with medical treatments but also as a relay and maintenance treatment to limit the reappearance of plaques.
-
For whom?From age 12Adults
-
Price
-
TextureLight fragrance, respects coloring.
Patient relations
-
Application tips
Treatment phase: 3 times a week for 4 weeks.
Maintenance phase: 1 a week, alternating with gentle shampoo.
Rinse in case of contact with eyes. -
In combination with the following treatments
- Dermocorticoids (betamethasone, hydrocortisone, clobetasol).- Association of vitamin D3 and dermocorticoids (calcipotriol + betamethasone).(Shampoo in the morning to rinse off medicated topicals applied in the evening.)
Ingredients
Active ingredients:
1st innovative active ingredient from Pierre Fabre biotechnology (technique d’extraction brevetée), CELASTROL®, is of 100% natural origin and produced through the cultivation of plant cells.
Active ingredient derived from an extract of chicory root, Cichorium intybus, rich in oligofructosans.
Keratolytic active ingredient inducing a significant loss of cohesion at the level of the stratum corneum: desquamation of thick patches on the scalp.
Active ingredient derived from shale oil obtained by distillation of rocks, which slows down cell renewal ( in vitrotest).
Formula details:
Click on an ingredient type to highlight it in the list
Clinical results and publications
Efficacy results
Pruritus from the 1st applications (2).
Induration at 1 month (3).
Improvement in quality of life (4).
Tolerance results
Tolerance only:
Very good skin tolerance (1).
Tolerance in combination with other treatments:
Excellent tolerance in combination with medicated topicals (5).
Legal Notice
(1) Clinical study on 54 subjects with light to moderate psoriasis on the scalp. 4 week attack phase: 3 shampoos per week
(2) Self-evaluation of the intensity of pruritus at D8.
(3) Clinical assessment of plaque induration at D29.
(4) DLQI score at D29.
(5) Clinical study of tolerance in combination with drug treatments (dermocorticoid alone or in combination with a vitamin D analogue) in 31 adult subjects with scalp psoriasis. Shampoo 3 times a week for 4 weeks. Skin tolerance rated by investigators.
Illustrative photos: Patient 1 (treated)
D0
Attack treatment: 3x per week
D28
Attack treatment: 3x per week
D56
Maintenance: 1x per week
Illustrative photos: Patient 2 (untreated)
D0
Attack treatment: 3x per week
J28
Attack treatment: 3x per week
J56
Maintenance: 1x per week
Discover the range
Contact us
Would you like to meet a sales representative?
Our medical sales representatives come to your workplace to answer all your questions about our brands and products.
The product concerned may not be available in your country. Please contact your medical sales representative for further information.
Have you noticed any side effects?
The safety and well-being of your patients is our priority. If you notice an unlisted adverse reaction to one of our products, please contact us without delay. We look forward to hearing from you!
Our commitments
Made in France
Product manufactured in our factories in France.
Conscious Care
Pierre Fabre Laboratories brands, including Ducray Dermatological Laboratories, have joined forces and collectively created Conscious Care: a dermo-cosmetic of the future that acts conscientiously towards its entire ecosystem.
Supporting associations
Ducray Dermatological Laboratories support 14 patient associations around the world, with the objective of sharing information on pathologies to improve their management.
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.